Wells Fargo & Company A Tyr Pharma Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Wells Fargo & Company holds 2,500 shares of LIFE stock, worth $4,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,500

Previous 1,500 66.67%

Holding current value

$4,650

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.51 - $2.24 $1,510 - $2,240	1,000 Added 66.67%	2,500 $4,000
Q2 2024 Aug 13, 2024	SELL	$0.0 - $2.07 $0 - $852	-412 Reduced 21.55%	1,500 $2,000
Q1 2024 May 10, 2024	BUY	$1.42 - $2.02 $9 - $14	7 Added 0.37%	1,912 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.11 - $1.51 $33 - $45	30 Added 1.6%	1,905 $2,000
Q3 2023 Nov 13, 2023	SELL	$1.55 - $2.23 $24 - $35	-16 Reduced 0.85%	1,875 $2,000
Q2 2023 Aug 15, 2023	BUY	$1.72 - $2.57 $63 - $95	37 Added 2.0%	1,891 $4,000
Q1 2023 May 12, 2023	BUY	$1.88 - $2.5 $298 - $397	159 Added 9.38%	1,854 $3,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $2.49 $18 - $22	9 Added 0.53%	1,695 $3,000
Q3 2022 Nov 14, 2022	BUY	$2.79 - $4.15 $30 - $45	11 Added 0.66%	1,686 $6,000
Q2 2022 Aug 12, 2022	BUY	$2.63 - $5.61 $42 - $89	16 Added 0.96%	1,675 $4,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $517 - $674	71 Added 4.47%	1,659 $12,000
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $6,292 - $18,607	1,491 Added 1537.11%	1,588 $15,000
Q2 2021 Aug 16, 2021	BUY	$3.62 - $4.88 $126 - $170	35 Added 56.45%	97 $0
Q4 2020 Feb 09, 2021	BUY	$3.07 - $4.66 $21 - $32	7 Added 12.73%	62 $0
Q3 2020 Nov 05, 2020	BUY	$3.23 - $5.39 $6 - $10	2 Added 3.77%	55 $0
Q2 2020 Aug 13, 2020	BUY	$2.55 - $4.58 $17 - $32	7 Added 15.22%	53 $0
Q1 2020 May 14, 2020	BUY	$2.17 - $7.06 $99 - $324	46 New	46 $0

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company A Tyr Pharma Inc Transaction History